PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 193 filers reported holding PDL BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $88,000 | -53.9% | 30,114 | -55.6% | 0.05% | +2.1% |
| Q1 2020 | $191,000 | +389.7% | 67,837 | +459.0% | 0.05% | +860.0% |
| Q4 2019 | $39,000 | -72.1% | 12,135 | -81.3% | 0.01% | -73.7% |
| Q3 2019 | $140,000 | -79.3% | 64,754 | -69.9% | 0.02% | -75.0% |
| Q2 2019 | $675,000 | -23.6% | 215,083 | -9.4% | 0.08% | -15.6% |
| Q1 2019 | $884,000 | +24.5% | 237,513 | -2.9% | 0.09% | +9.8% |
| Q4 2018 | $710,000 | -18.0% | 244,700 | -25.6% | 0.08% | +70.8% |
| Q3 2018 | $866,000 | -13.9% | 329,100 | -23.5% | 0.05% | -4.0% |
| Q2 2018 | $1,006,000 | -12.7% | 430,100 | +9.6% | 0.05% | -18.0% |
| Q1 2018 | $1,153,000 | +17.8% | 392,276 | +9.8% | 0.06% | +1.7% |
| Q4 2017 | $979,000 | -58.8% | 357,181 | -49.1% | 0.06% | -63.0% |
| Q3 2017 | $2,377,000 | +21.2% | 701,081 | -11.7% | 0.16% | +26.6% |
| Q2 2017 | $1,962,000 | -46.7% | 794,281 | -51.1% | 0.13% | -35.4% |
| Q1 2017 | $3,684,000 | +9.4% | 1,622,781 | +2.2% | 0.20% | -1.5% |
| Q4 2016 | $3,366,000 | -33.9% | 1,587,756 | +4.4% | 0.20% | -26.6% |
| Q3 2016 | $5,096,000 | +22.7% | 1,521,224 | +15.1% | 0.27% | +19.1% |
| Q2 2016 | $4,152,000 | +37.8% | 1,322,151 | +46.1% | 0.23% | +19.8% |
| Q1 2016 | $3,014,000 | -9.6% | 905,024 | -3.9% | 0.19% | +17.8% |
| Q4 2015 | $3,334,000 | -7.1% | 941,736 | +31.9% | 0.16% | -7.4% |
| Q3 2015 | $3,590,000 | -41.5% | 713,723 | -25.3% | 0.18% | -25.4% |
| Q2 2015 | $6,140,000 | +54.6% | 954,853 | +69.2% | 0.24% | +49.4% |
| Q1 2015 | $3,971,000 | +57.4% | 564,435 | +72.5% | 0.16% | -10.2% |
| Q4 2014 | $2,523,000 | +3.4% | 327,184 | +0.2% | 0.18% | +37.5% |
| Q3 2014 | $2,440,000 | +3.8% | 326,577 | +34.5% | 0.13% | +20.8% |
| Q2 2014 | $2,351,000 | +111.0% | 242,872 | +81.2% | 0.11% | +34.2% |
| Q1 2014 | $1,114,000 | +11.6% | 134,072 | +13.3% | 0.08% | 0.0% |
| Q4 2013 | $998,000 | -51.8% | 118,288 | -54.5% | 0.08% | -51.8% |
| Q3 2013 | $2,071,000 | +19.5% | 259,801 | +15.7% | 0.16% | -20.4% |
| Q2 2013 | $1,733,000 | – | 224,458 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |